This development has become especially prominent in China, where new research reveals a sharp rise in cancer cases linked to obesity within this age group. As lifestyles evolve and obesity rates ...
Obesity increases risks from Covid-19 ... and have an unhealthy work schedule". China is not the only country to have seen an increase in the number of overweight or obese people in recent ...
A new study reveals the rising burden of liver cancer, highlighting the significant impact of metabolic risk factors like ...
More than 180 million people live with obesity in China. According to Chinese business news website Yicai, a dose of four Wegovy injections will cost 1,400 yuan (£153; $194), a fraction of the ...
Data from Hengrui’s Phase II trial for its GLP-1/GIP product demonstrated a statistically significant mean weight loss of ...
This three-part series from BioWorld highlights the strengths and weaknesses of major players in China’s obesity and diabetes market, including the pressing line of Chinese semaglutide biosimilars, ...
This global (excluding China) study, which will enroll patients who are obese or overweight, is slated to begin in 2025. “Obesity has become a major risk factor for a number of chronic diseases ...
To foray into the lucrative obesity market, Merck MRK announced that ... Hansoh has an option to co-promote or solely commercialize HS-10535 in China. For the deal, Merck will record a pre-tax ...